When the blood selenium increment was within a specific range, the risk of CVD death decreased in a dose-dependent manner, but it seemed to start to increase when the increment exceeded 35 g/L [116]
Longer-term safety, of course, still has to be confirmed in larger studies, but there is at least a structured dataset and regulatory oversight guiding dose selection and monitoring
Until more definitive evidence becomes available, clinical decisions must be made on an individual basis, weighing the potential benefits against theoretical and observed risks
Recalls & Warnings May 01, 2023 TruVision Recalls Products Due to Presence of Potentially Dangerous Ingredients On April 27, 2023, TruVision Health issued a recall of various dietary supplement products because they contain hordenine and/or octodrine/DMHA, compounds that the FDA considers to be possibly unsafe and which are not permitted to be sold as dietary supplements
Distant metastases, most commonly to the lungs, liver, and bones, occur in approximately 4050% of patients and are a major cause of mortality (Widemann & Italiano, 2018)